Yeah, I heard that last night while relaxing and smoking a decent but not great cigar. But words mean shit in the biotech sector. Results, commercialization and revenue is what matters. Also trading not on the OTC BB as well. The pent up value in AMBS is great. No denying that. But Gerald yesterday echoed what I have been saying for eons. Trading on the OTCBB is a death sentence. None of the business developments have made a dent in the PPS and won't unlock that value until an uplist. The sooner the better.